American pharmaceutical giant Eli Lilly has tapped Huntsville, Alabama, as the location for its third orforglipron ...

Eli Lilly and Company announced Tuesday it was investing more than $6 billion in a new manufacturing facility in Huntsville, ...

Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in ...

The site is the third of four new facilities in the U.S. that the pharmaceutical company plans to announce, Eli Lilly said.

Eli Lilly and Company (NYSE: LLY) today announced plans to invest more than $6 billion in a new manufacturing facility in ...

Eli Lilly chose Huntsville for its newest manufacturing plant — a $6 billion project and the largest single-site investment ...

A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...

Notably, the Huntsville site will be among those that will manufacture orforglipron, Lilly’s first oral, small molecule GLP-1 ...

Lilly’s planned Huntsville site is part of the drugmaker’s commitment to add four U.S. manufacturing sites through a $27 ...

The pharmaceutical giant's investment in Huntsville will be a huge boost to the local economy, underscoring its rising ...

Eli Lilly announced plans to construct a $6 billion pharmaceutical manufacturing facility in Huntsville, aiming to enhance ...

A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...